226 related articles for article (PubMed ID: 26113842)
1. The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.
Navari M; Etebari M; De Falco G; Ambrosio MR; Gibellini D; Leoncini L; Piccaluga PP
Front Microbiol; 2015; 6():556. PubMed ID: 26113842
[TBL] [Abstract][Full Text] [Related]
2. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
[TBL] [Abstract][Full Text] [Related]
3. Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.
Navari M; Fuligni F; Laginestra MA; Etebari M; Ambrosio MR; Sapienza MR; Rossi M; De Falco G; Gibellini D; Tripodo C; Pileri SA; Leoncini L; Piccaluga PP
Front Microbiol; 2014; 5():728. PubMed ID: 25566237
[TBL] [Abstract][Full Text] [Related]
4. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.
Lenze D; Leoncini L; Hummel M; Volinia S; Liu CG; Amato T; De Falco G; Githanga J; Horn H; Nyagol J; Ott G; Palatini J; Pfreundschuh M; Rogena E; Rosenwald A; Siebert R; Croce CM; Stein H
Leukemia; 2011 Dec; 25(12):1869-1876. PubMed ID: 21701491
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and
Liao HM; Liu H; Chin PJ; Li B; Hung GC; Tsai S; Otim I; Legason ID; Ogwang MD; Reynolds SJ; Kerchan P; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Ayers LW; Pfeiffer RM; Bhatia K; Goedert JJ; Lo SC; Mbulaiteye SM
Front Oncol; 2022; 12():812224. PubMed ID: 35340265
[TBL] [Abstract][Full Text] [Related]
6. The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma.
Ambrosio MR; Navari M; Di Lisio L; Leon EA; Onnis A; Gazaneo S; Mundo L; Ulivieri C; Gomez G; Lazzi S; Piris MA; Leoncini L; De Falco G
Infect Agent Cancer; 2014; 9():12. PubMed ID: 24731550
[TBL] [Abstract][Full Text] [Related]
7. Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma.
El-Mallawany NK; Day N; Ayello J; Van de Ven C; Conlon K; Fermin D; Basrur V; Elenitoba-Johnson K; Lim M; Cairo MS
Eur J Cancer; 2015 Jan; 51(1):92-100. PubMed ID: 25466511
[TBL] [Abstract][Full Text] [Related]
8. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
9. Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants.
Rochford R
Ann Lymphoma; 2021 Sep; 5():. PubMed ID: 34888589
[TBL] [Abstract][Full Text] [Related]
10. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
11. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
Klein G; Klein E; Kashuba E
Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
[TBL] [Abstract][Full Text] [Related]
15. Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma.
Oduor CI; Movassagh M; Kaymaz Y; Chelimo K; Otieno J; Ong'echa JM; Moormann AM; Bailey JA
Front Microbiol; 2017; 8():501. PubMed ID: 28400759
[TBL] [Abstract][Full Text] [Related]
16. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
17. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiological analysis and literature review of the prevalence of Epstein-Barr virus and herpesvirus infections in pediatric cases with non-Hodgkin lymphoma in Central Europe.
Vaillant V; Reiter A; Zimmermann M; Wagner HJ
Pediatr Blood Cancer; 2019 Jul; 66(7):e27752. PubMed ID: 30977593
[TBL] [Abstract][Full Text] [Related]
19. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
Rooney C; Howe JG; Speck SH; Miller G
J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
[TBL] [Abstract][Full Text] [Related]
20. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
